AGEN Agenus Inc.
$6.94▲ +0.73%
Healthcare
Other
After hours
$6.85▼ -1.30%
Sep 11, 7:47 PM ET
Volume 790.5K
Avg Volume (10D) 885.5K
Key Metrics & Fundamentals
Market Cap
$312.44M
P/E Ratio
2.3
Div Yield
–%
52W Range
2.71 - 8.85
% vs 50 MA
5.33%
% vs 200 MA
62.02%
RSI-14
45.4
MACD Histogram
-0.2200
Beta (1Y vs SPY)
1.58
Free Cash Flow
-$31.20M
Gross Rev
$34.52M
Gross Profit
$19.76M
EBITDA
$15.19M
COGS
$14.76M
Operating Exp
$8.47M
Operating Income
$11.29M
EBIT
$11.29M
Pretax Income
-$567,000
Net Income
-$550,000
EPS (Diluted)
-0.01
Price & Volume History
Loading chart…
Recent News
Agenus to Present Three-Year Overall Survival Data for BOT+BAL in Recurrent Ovarian Cancer at IGCS 2026
Business Wire · Sep 10, 2026 11:30 AM
Agenus to Participate in Upcoming September Investor Conferences
Business Wire · Aug 31, 2026 11:30 AM
Agenus Announces Peer-Reviewed Publication Linking BOT+BAL’s Durable Survival in MSS Metastatic Colorectal Cancer to Its Distinct Immune-Priming Mechanism
Business Wire · Aug 28, 2026 2:07 PM
Agenus Announces Updated NEST Phase 2 Publication Reporting Deep Pathologic Responses and No Observed Recurrences with Neoadjuvant BOT+BAL in Resectable Colon Cancer
Business Wire · Aug 26, 2026 2:05 PM
Checkpoint Inhibitor Refractory Cancer Market Outlook is Predicted to Improve by 2036, Biopharma Companies Advance Novel Immuno-Oncology Candidates | DelveInsight
PR Newswire · Aug 19, 2026 2:31 PM
Agenus (AGEN) Stock Fair Value Falls After Analysts Rework Pipeline And Financing Assumptions
Simply Wall St. · Aug 16, 2026 1:07 PM
Agenus (AGEN) Reports Q2 Loss, Tops Revenue Estimates
Zacks · Aug 7, 2026 9:45 PM
Agenus Files for Resale of Up to 78 Million Shares
MT Newswires · Aug 7, 2026 8:51 PM
Agenus: Q2 Earnings Snapshot
Associated Press · Aug 7, 2026 8:42 PM
Agenus Reports Second Quarter 2026 Results and Advances Phase 3 ROBBIN Trial of BOT+BAL in Neoadjuvant MSS Colon Cancer
Business Wire · Aug 6, 2026 11:30 AM
Financial Overview - Income Statement
Quarterly
Jun 2026
See AGEN's money flow as a full page
Social Sentiment
No Reddit posts found for AGEN.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.